Processa Pharmaceuticals, Inc. (PCSA)
3.36
-0.10
(-2.89%)
USD |
NASDAQ |
Jan 09, 16:00
3.38
+0.02
(+0.60%)
After-Hours: 20:00
Processa Pharmaceuticals EPS Diluted (Quarterly): -1.808 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Kodiak Sciences, Inc. | -1.163 |
| Pyxis Oncology, Inc. | -0.3517 |
| NovaBay Pharmaceuticals, Inc. | -0.22 |
| Palatin Technologies, Inc. | 4.258 |
| Theriva Biologics, Inc. | -0.4507 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -3.437M |
| Total Expenses (Quarterly) | 3.437M |
| Enterprise Value | 1.305M |
| Earnings Yield | -799.9% |
| Normalized Earnings Yield | -799.87 |